Tubal patency after clinical treatment of unruptured ectopic pregnancy

International Journal of Gynecology and Obstetrics

Volumn 88, Issue 3, 2005, Pages 309-313

  Elito Jr , J ^a   Han, K K ^a   Camano, L ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Chorionic gonadotropic hormone; Ectopic pregnancy; Expectant management; Hysterosalpingography; Methotrexate

Indexed keywords

METHOTREXATE;

ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ECTOPIC PREGNANCY; FEMALE; FOLLOW UP; HUMAN; HYSTEROSALPINGOGRAPHY; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROSPECTIVE STUDY; STATISTICAL SIGNIFICANCE; SURGICAL TECHNIQUE; UTERINE TUBE DISEASE; UTERINE TUBE PREGNANCY;

EID: 14144254820     PISSN: 00207292     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijgo.2004.12.018     Document Type: Article

References (12)

1. Centers for Disease Control and Prevention Ectopic pregnancy-United States, 1990-1992 MMWR 43 1995 46 48
2. W.M. Ankun, F. Van der Veen, J.V. Hamerlynk, and F.B. Lammes Transvaginal sonography and human chorionic gonadotrophin measurements in suspected ectopic pregnancy: a detailed analysis of a diagnostic approach Hum. Reprod. 8 1993 1307 1311
3. A. Debby, A. Golan, O. Sadan, H. Zakut, and M. Glezerman Fertility outcome following combined methotrexate treatment of unruptured extrauterine pregnancy BJOG 107 2000 626 630
4. M. Rantala, and J. Mäkinen Tubal patency and fertility outcome after expectant management of ectopic pregnancy Fertil. Steril. 68 1997 1043 1046
5. B.W. Mol, P. Swart, P.M. Bossut, and F. Van Der Veen Hysterosalpingography an important tool in predicting fertility outcome? Fertil. Steril. 67 1997 663 669
6. T.G. Stovall, F.W. Ling, L.A. Gray, S.A. Carson, and J.E. Buster Methotrexate treatment of unruptured ectopic pregnancy: a report of 100 cases Obstet. Gynecol. 77 1991 749 753
7. J. Elito Jr., A. Reichmann, M. Uchiyama, and L. Camano Predictive score for the systemic treatment of unruptured ectopic pregnancy with a single dose of methotrexate Int. J. Gynecol. Obstet. 67 1999 75 79
8. I.Z. Glatstein, L.A. Sleeper, Y. Law, A. Simon, A. Adoni, and N. Laufer Observer variability in the diagnosis and management of the hysterosalpingogram Fertil. Steril. 67 1997 233 237
9. N. Job-Spira, Z.H. Fernadez, and J. Bouyer Ruptured tubal ectopic pregnancy risk factors and reproductive outcome: results of a population-based study in France Am. J. Obstet. Gynecol. 180 1999 93844
10. J.W. Mass, J.L. Evers, G. Riet, and A.G. Kessels Pregnancy rate following normal versus abnormal hysterosalpingography findings: a meta-analysis Gynecol. Obstet. Invest. 43 1997 79 83
11. E. Zohav, O. Gemer, and S. Segal Reproductive outcome after expectant management of ectopic pregnancy Eur. J. Obstet. Reprod. Biol. 66 1996 1 2
12. G.H. Lipscomb, M.L. McCord, T.G. Stovall, G. Huff, and F.W. Ling Predictors of success of methotrexate treatment in women with tubal ectopic pregnancies N. Engl. J. Med. 341 1999 1874 1878